Overview
[18F]-DPA-714 PET/CT (Positron Emission Tomography/Computerized Tomography) in Triple Negative Breast Cancers
Status:
Completed
Completed
Trial end date:
2021-07-21
2021-07-21
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
This phase II study is assessing the correlation between M1/M2 macrophage polarization determined by tumor immunohistochemistry analysis and [18F]DPA-714 PET/CT binding (qualitative and texture analysis) in patients with operable triple negative breast cancer.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Institut Cancerologie de l'OuestCollaborators:
SIRIC ILIAD
SIRIC ILIAD : regional consortium led by the health cooperation consortium
Criteria
Inclusion Criteria:- 18 Years and older
- Triple negative primary breast cancer based on immunohistochemical results as follows:
- Estrogen receptor < 10%
- And Progesterone receptors < 10%
- And HER2 (Human Epidermal Growth Factor Receptor-2) not amplified or not
overexpressed
- Patient with a primary tumor eligible for primary surgery
- Performance Status equal to 0 or 1
- Fertile patients must use effective contraception
- Patient must be affiliated to a Social Health Insurance
- Written informed consent
Exclusion Criteria:
- Patient with No triple negative breast cancer
- Patient with inflammatory breast cancer
- Patient with metastatic breast cancer
- Patient receiving cancer treatments such as chemotherapy, immunotherapy, biologic
response modifiers, hormonal therapy, and radiotherapy BEFORE the biopsy and PET scans
are performed
- Treated diabetes with fasting blood glucose > 10 mmol/L
- Patient who received antibiotics and/or steroidal and/or non-steroidal
anti-inflammatory drugs within 30 days PRIOR to [18F]-DPA-714 PET scan
- Contraindication to MRI (implants or metallic prosthesis, severe claustrophobia,
pacemaker ...)
- Patient deprived of liberty, under a measure of safeguard of justice, under
guardianship or under the authority of a guardian
- Pregnant or nursing patient
- Agitation; impossibility of lying motionless for at least 1 hour, or known
claustrophobia